Routine intraoperative completion angiography after coronary artery bypass grafting and 1-stop hybrid revascularization results from a fully integrated hybrid catheterization laboratory/operating room.
暂无分享,去创建一个
John A McPherson | S. Hoff | David X M Zhao | J. Mcpherson | J. Cleator | K. Boudoulas | J. Balaguer | A. Thompson | Steven J Hoff | J. Fredi | Robert N Piana | J. Byrne | M. Leacche | R. Ahmad | Annemarie Thompson | M. Robbins | Susan S Eagle | J. Greelish | R. Deegan | M. Pretorius | R. Piana | John G Byrne | David X Zhao | Marzia Leacche | Jorge M Balaguer | Konstantinos D Boudoulas | Julie A Damp | James P Greelish | Rashid M Ahmad | Stephen K Ball | John H Cleator | Robert J Deegan | Pete P Fong | Joseph L Fredi | Henry S Jennings | Mias Pretorius | Mark A Robbins | David A Slosky | S. Eagle | H. Jennings | S. Ball | D. Slosky | P. Fong | Annemarie Thompson | J. Byrne
[1] G. Feuchtner,et al. Risk factors of postoperative nephropathy in patients undergoing innovative CABG and intraoperative graft angiography. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[2] Bari Investigators. The final 10-year follow-up results from the BARI randomized trial. , 2007 .
[3] Prevent Iv Investigators. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. , 2005 .
[4] Jeffrey W Moses,et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.
[5] Mary E. Russell,et al. TAXUS I: Six- and Twelve-Month Results From a Randomized, Double-Blind Trial on a Slow-Release Paclitaxel-Eluting Stent for De Novo Coronary Lesions , 2003, Circulation.
[6] D. Taggart,et al. Intraoperative imaging techniques to assess coronary artery bypass graft patency. , 2007, The Annals of thoracic surgery.
[7] A. Colombo,et al. Drug-Eluting Stent Update 2007: Part III: Technique and Unapproved/Unsettled Indications (Left Main, Bifurcations, Chronic Total Occlusions, Small Vessels and Long Lesions, Saphenous Vein Grafts, Acute Myocardial Infarctions, and Multivessel Disease) , 2007, Circulation.
[8] Kevin P. Bliden,et al. Clopidogrel for Coronary Stenting Response Variability, Drug Resistance, and the Effect of Pretreatment Platelet Reactivity , 2003, Circulation.
[9] Jin Li-jun,et al. The final 10-year follow-up results from the BARI randomized trial. , 2007, Journal of the American College of Cardiology.
[10] Ameet Bakhai,et al. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial , 2002, The Lancet.
[11] P. Serruys,et al. Drug-Eluting Stent Update 2007: Part II: Unsettled Issues , 2007, Circulation.
[12] H. Nathoe,et al. A comparison of on-pump and off-pump coronary bypass surgery in low-risk patients☆ , 2003 .
[13] Richard Tran,et al. Simultaneous hybrid coronary revascularization reduces postoperative morbidity compared with results from conventional off-pump coronary artery bypass. , 2008, The Journal of thoracic and cardiovascular surgery.
[14] S. Pauker,et al. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. , 2003, Journal of the American College of Cardiology.
[15] K M Taylor,et al. The platelet in cardiopulmonary bypass. , 1998, The Annals of thoracic surgery.
[16] G. Angelini,et al. Hybrid coronary revascularization in the era of drug-eluting stents. , 2004, The Annals of thoracic surgery.
[17] W. C. Sheldon,et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. , 1986, The New England journal of medicine.
[18] 최동훈,et al. A Paclitaxel-Eluting Stent for the Prevention of Coronary Restenosis , 2003 .
[19] R. Califf,et al. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. , 2005, JAMA.
[20] L. Finch. A hybrid approach , 1998 .
[21] Patrick W Serruys,et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. , 2005, Journal of the American College of Cardiology.
[22] F. Loop,et al. The effect of coronary reoperation on the survival of patients with stenoses in saphenous vein bypass grafts to coronary arteries. , 1993, The Journal of thoracic and cardiovascular surgery.
[23] E. Hannan,et al. Drug-Eluting Stents vs Coronary-Artery Bypass Grafting in Multivessel Coronary Disease , 2008 .
[24] G. Breithardt,et al. Sirolimus-eluting stents at two years: a pooled analysis of SIRIUS, E-SIRIUS, and C-SIRIUS with emphasis on late revascularizations and stent thromboses. , 2006, The American journal of cardiology.
[25] R. de Caterina,et al. Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology. , 2004, European heart journal.
[26] L. Cohn,et al. Staged initial percutaneous coronary intervention followed by valve surgery ("hybrid approach") for patients with complex coronary and valve disease. , 2004, Journal of the American College of Cardiology.
[27] M. Carrier,et al. Quantitative angiographic assessment of coronary anastomoses performed without cardiopulmonary bypass. , 1999, The Journal of thoracic and cardiovascular surgery.
[28] N. Smedira,et al. A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study. , 2006, Journal of Thoracic and Cardiovascular Surgery.
[29] T. Chalmers,et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration , 1994, The Lancet.